Cullinan Therapeutics, Inc.(CGEM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Cullinan Therapeutics, Inc. (CGEM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CGEM is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of CGEM by reported 13-F value include MPM BioImpact, Lynx1 Capital Management, BVF, based on the most recent SEC filings. CGEM trades on the Nasdaq exchange and files with the SEC under CIK 1789972. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGEM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cullinan Therapeutics, Inc. directly from SEC EDGAR.